Key terms
About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NVO news
Today
10:39am ET
Novo Nordisk Under Fire, Post-Ozempic Study
Mar 25
11:27am ET
Novo Nordisk Updates Corporate Governance
Mar 25
6:10am ET
Novo Nordisk to acquire Cardior Pharmaceuticals for up to EUR 1.025B
Mar 22
7:30am ET
Argus cuts Pfizer to Hold on headwinds to revenue growth
Mar 22
7:00am ET
Novo Nordisk’s Awiqli® Set to Transform Diabetes Care
Mar 21
1:27pm ET
Novo Nordisk Thrives with Record Patient Reach
Mar 21
11:58am ET
Novo Nordisk receives positive CHMP opinion on Awiqli for diabetes
Mar 21
11:00am ET
Medicare Part D may cover Novo obesity drug, WSJ reports
Mar 20
12:34pm ET
CBO analyst comments on obesity drugs similar to October 2023 report
Mar 20
12:24pm ET
Eli Lilly, Novo Nordisk lower after CBO analyst comments on obesity drugs
Mar 20
12:20pm ET
Lilly, Novo lower after CBO analyst says obesity drugs could raise deficit
Mar 20
6:20am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 18
2:52pm ET
Novo Nordisk price target raised to DKK 900 from DKK 850 at Berenberg
Mar 18
12:27pm ET
Novo Nordisk Advances Share Buyback Program
Mar 18
10:41am ET
Oprah to host TV special discussing weight loss, CNN reports
Mar 15
4:47pm ET
Eli Lilly’s (NYSE:LLY) Weight-Loss Drug Outshines Wegovy for First Time
Mar 15
4:55am ET
Piper Sandler healthcare/pharma analysts hold analyst/industry conference call
Mar 14
12:50pm ET
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Mar 14
11:41am ET
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Mar 13
11:00am ET
European Stocks: Unnoticed Records, Overlooked Opportunities
Mar 13
7:26am ET
Corbus Pharmaceuticals price target raised to $58 from $51 at Oppenheimer
Mar 13
5:24am ET
Novo Nordisk downgraded to Neutral from Outperform at Oddo BHF
Mar 12
5:00pm ET
Piper Sandler healthcare/pharma analysts hold analyst/industry conference call
Mar 08
1:48pm ET
Novo Nordisk reports FDA approved label expansion for Wegovy
Mar 08
11:55am ET
Novo Nordisk price target raised to DKK 1,100 from DKK 950 at Deutsche Bank
Mar 08
11:09am ET
Novo Nordisk price target raised to DKK 1,050 from DKK 900 at Barclays
Mar 08
7:04am ET
Novo Nordisk’s (NYSE:NVO) Wegovy Set to Storm China’s Weight Loss Market
Mar 08
6:45am ET
Major Stocks Scale New Highs as Indices Set New Records
Mar 08
6:24am ET
Novo Nordisk surpasses Tesla in valuation, Reuters says
Mar 07
3:34pm ET
Novo results raising the bar for Viking’s oral VK2735, says Oppenheimer
Mar 07
1:49pm ET
William Blair healthcare analysts hold analyst/industry conference call
Today
6:50am ET
Prediction: This Will Be the Next "Magnificent Seven" Stock
Mar 26
10:35am ET
Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy?
Mar 26
5:51am ET
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
Mar 25
9:07am ET
Uncovering Hidden Gems: 1 AI-Powered Healthcare Stock Set to Dominate the Market
Mar 25
6:25am ET
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
Mar 24
9:15am ET
Is Viking Therapeutics Stock a Millionaire Maker?
Mar 22
10:30am ET
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
Mar 22
7:15am ET
Did Eli Lilly Just One-Up Novo Nordisk?
Mar 21
10:15am ET
Novo Nordisk's New Weight Loss Drug Could Be Better Than Ozempic and Wegovy
Mar 20
8:30am ET
Will Novo Nordisk Overtake Eli Lilly as the Most Valuable Healthcare Stock?
Mar 19
10:00am ET
Is Novo Nordisk on the Verge of Another Blockbuster Drug?
Mar 19
7:30am ET
Did Novo Nordisk Just Get a Jump on Eli Lilly?
Mar 19
5:50am ET
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?
Mar 17
2:28pm ET
Novo Nordisk Isn't in The "Magnificent Seven," but Here's Why I Think It Should Be
Mar 17
9:46am ET
Novo Nordisk Is Already Working on Wegovy's Successor -- Time to Buy?
Mar 17
9:00am ET
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
Mar 17
5:50am ET
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Mar 17
3:24am ET
Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?
Mar 15
10:15am ET
Novo Nordisk Just Scored a Huge Win. And It's Not Related to Ozempic
Mar 15
7:46am ET
Move Over, Tesla! These 6 Stocks Could Replace It in the "Magnificent 7"
Mar 15
5:50am ET
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Mar 12
8:31pm ET
Why Novo Nordisk Stock Was a Winner Today
Mar 12
7:45am ET
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant
Mar 10
9:29am ET
Forget Tesla: I Think This Stock Should Replace It in the "Magnificent Seven"
Mar 10
4:33am ET
Is Novo Nordisk a Buy After Its New Obesity Candidate's Success in a Clinical Trial?
Mar 07
12:05pm ET
Why Viking Therapeutics Stock Is Plunging Today
Mar 07
11:49am ET
Why Novo Nordisk Stock Is Jumping Today (Hint: It's Not Because of Ozempic or Wegovy)
Mar 06
5:50am ET
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
Mar 05
6:23pm ET
Why Novo Nordisk Stock Tumbled by Nearly 3% on Tuesday
Mar 05
11:16am ET
A New Competitor to Wegovy Could Be on the Way. Should Novo Nordisk Be Worried?
Mar 05
9:53am ET
Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why
No recent press releases are available for NVO
NVO Financials
Key terms
Ad Feedback
NVO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range